Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date28 Apr 1973 |
100 Clinical Results associated with RMJ SGRpA
0 Patents (Medical) associated with RMJ SGRpA
100 Deals associated with RMJ SGRpA
100 Translational Medicine associated with RMJ SGRpA